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DIABETES MELLITUS
• Diabetes mellitus (DM) is a disease of high blood sugar and disordered 
carbohydrate, fat and protein metabolism. 
• DM causes damage to blood vessels throughout the body. 
• The small vessels of the retina are commonly affected. This causes damage to 
the retina itself and ultimately affects vision.
• In type 1 DM there is autoimmune destruction of the insulin secreting cells in 
the pancreas causing it to stop producing any insulin. 
• Type 1 DM occurs mainly in younger people and requires insulin treatment to 
reduce blood sugars.
• Type 2 DM is more common and usually occurs in older people. It is often 
treated with tablets to reduce the blood sugar.
• In type 2 DM there is often a degree of insulin resistance as well as reduced 
production. 
• Diabetes is a serious, long-term condition with a major 
impact on the lives and well-being of individuals, families, 
and societies worldwide.
• The global diabetes prevalence in 2019 is estimated to be 
9.3% (463 million people), rising to 10.2% (578 million) by 
2030 and 10.9% (700 million) by 2045. 
• The prevalence is higher in urban (10.8%) than rural (7.2%) 
areas, and in high-income (10.4%) than low-income 
countries (4.0%). 
• One in two (50.1%) people living with diabetes do not know 
that they have diabetes
EPIDEMIOLOGY
• Over the last few years both diabetes and diabetic retinopathy have 
become increasingly common, particularly in low and middle-income 
countries.
• Increased prevalence of obesity; this predisposes to type 2 diabetes.
• Dietary changes.
• Increased life expectancy: people are living longer in most areas of the world. 
There are therefore more years in which they might develop diabetes and its 
complications.
• Lifestyle. Many people are leading increasingly sedentary lifestyles. This leads 
to weight gain and an increased risk of type 2 diabetes.
• Of an estimated 285 million people with diabetes mellitus 
worldwide, approximately one third have signs of DR and of 
these, a further one third of DR is vision-threatening DR, 
including diabetic macular edema (DME).
• Diabetic Retinopathy (DR) is the leading cause of vision loss 
in adults aged 20–74 years
• The identification of established modifiable risk factors for 
DR such as hyperglycemia and hypertension has provided 
the basis for risk factor control in preventing onset and 
progression of DIABETIC RETINOPATHY.
Diabetic Eye Disease Anterior Segment
• Manifest refractive changes
1.5x more likely to be myopic
Investigate in adult-onset myopia
• Cataract formation
More commonly cortical cataract
• Glaucoma
• IIIrd and VIth cranial nerve palsies
Resolve in 2-6 months
No pupil involvement
Diabetic Eye Disease Anterior Segment
• Recurrent corneal epithelial erosions and reduced 
corneal sensitivity
• Blepharitis, styes and chalazion
• Rubeosis Iridis
Sign of advanced diabetic eye disease
Growth starts at pupil margin
Leads to acute ACG
Iris new vessels
DIABETIC RETINOPATHY
NORMAL FUNDUS
• The eye is an excellent window through which the blood 
vessels and blood circulation in the body can be seen. 
• The retinal circulation can be seen in great detail with the 
direct ophthalmoscope, which gives an image of the retina 
and its blood vessels about 15 times larger than their actual 
size. 
• Some ophthalmoscopes also have a green filter in them. This 
is very useful because it makes the retinal blood vessels and 
any blood that has leaked in the retina much more obvious.
• The normal fundus should have no visible haemorrhages or patches 
of exudate and the presence of either of these suggests some 
underlying pathology.
• Vascular disease can cause haemorrhage and exudate anywhere or all 
over the fundus, but is often particularly concentrated around the 
optic disc and macula because the retinal blood supply is greatest 
here. 
• Although damage to these areas causes the most visual damage, they 
are fortunately the easiest areas to examine with an ophthalmoscope.
NORMAL FUNDUS
PATHOPHYSIOLOGY  OF DIABETIC RETINOPATHY
• A disease of the retinal microvasculature causing capillary leakage 
and occlusion
• Larger retinal vessels are located in the NFL and GCL
• Smaller retinal capillaries are located as deep as the INL
• The RPE and the retinal vasculature form the Blood-Retinal barrier
– Tight junctions
– No fenestrations
– Pericytes to control growth and provide support
– Basement membrane
PATHOPHYSIOLOGY  OF DIABETIC RETINOPATHY
• Abnormal changes to the microvasculature
– Thickening of the basement membrane
– Loss of pericytes
– Endothelial cell changes
• Basement membrane effect is accelerated ageing
• 75% pericyte loss removes support and allows bulging of the vessel 
wall (saccular MA)
• Extra growth of endothelial cells, forming tightloop MAs
• Loss of tight junctions breaks down the bloodretinal barrier
PATHOPHYSIOLOGY  OF DIABETIC 
RETINOPATHY
• Intra-retinal lipid exudates
– From leakage of plasma proteins and lipoproteins
– Located in OPL and form streaks or circles around areas of leakage
– Leakage at macula leads to visible oedema (focal and diffuse)
• Further leakage causes:
– Intra-retinal haemorrhages
– Flame-shaped haemorrhages when from superficial capillary bed
– Dot and blot haemorrhages when from deep capillary bed.
PATHOPHYSIOLOGY  OF DIABETIC 
RETINOPATHY
Capillary blockage due to:
– Thickening of basement membrane
– Sticky endothelial cell
– Increased blood viscosity as platelets aggregate and red blood cells 
change
– Causes local retinal hypoxia and nerve cell death
– Metabolic debris accumulates in the nerve fibres as axoplasmic
transport fails
– This material is located at the edges of ischaemic retina and appears 
as cotton wool spots
PATHOPHYSIOLOGY OF DIABETIC RETINOPATHY
The retinal hypoxic response
– Vascular endothelial growth factor is released from 
veins in areas of retinal hypoperfusion
– Initial response is limited to the capillary bed, in the 
dilation of pre-existing arterio-venous connections 
(IRMA)
– Later, outgrowths from the veins begin to grow 
through the ILM and across the face of the posterior 
vitreous forming new vessels (PDR)
PATHOPHYSIOLOGY OF DIABETIC RETINOPATHY
New vessels
– Immature, without normal pericytes numbers or tight junctions, but with 
fenestrations
– Prone to bleeding and leakage
– Accompanied by fibroblasts, forming fibrous attachments between vessels and 
vitreous
– Fibrous contraction causes:
• Bleeding
• Retinal detachment
• Retinal tears
• Rhegmatogenous retinal detachment
• VEGF leads to new vessel formation on the iris
(rubeosis iridis)

Risk factors for diabetic retinopathy
• Poor blood sugar control
• Increased blood pressure
• Increasing number of microaneurysms
• Duration of diabetes
• Protein and albumin in the urine
• Raised cholesterol
• Pregnancy
• Smoking


BDR
BDR
BDR
Diabetic macular oedema
• Loss of vision in BDR is due to macular oedema 
(CSMO)
• Signs of CSMO are:
• Retinal thickening 
• Exudates approaching fovea
• Focal oedema-exudates, microaneurysms
• Diffuse oedema
Macular oedema
Macular oedema
Macular oedema

Pre-retinal haemorrhage. This bleed has come from diabetic new vessels.
Laser treatment for macular oedema
• Oedema is caused by leaking vessels
• Laser destroys the leaking vessels 
• We use small numbers of laser applications using 
green light argon laser
• Treatment is directed at leaking microaneurysms in 
the centre of a ring of exudates
• 50 micron size, 0.1 second duration
INTRAVITREAL ANTI VEGF OR TRIAMCINOLONE INJECTION
Laser treatment
Signs that background DR is 
progressing  to proliferative DR
• Diffuse intra-retinal haemorrhages and 
microaneurysms in 4 quadrants
• Venous beading in 2 quadrants
• IRMA in 1 quadrant
• Very severe BDR (defined as any 2 of the above) has 
45% chance of progressing to of PDR in one year 
Signs that background DR is progressing  to 
proliferative DR
Pre-proliferative DR
• Pre-proliferative DR is indicated by:
• Severe or very severe BDR plus CWS
• CWS indicate poor perfusion and ischaemia
• Indicates that other clinical signs of progression should be 
looked for
• Patient is at high risk of developing PDR and should be 
reviewed more frequently or offered laser treatment
Pre-proliferative DR
Proliferative DR
•Characterised by:
• Pre-retinal fibrovascular proliferation
•Begins with:
• Fine new vessels (NV) with little fibrous tissue
• These increase in size and develop fibrosis
• Later regression of NV with fibrosis along back 
surface of the vitreous
Proliferative DR
PDR
• Problems are caused by traction of vitreous on fibrovascular 
complexes
• This leads to
• Pre-retinal haemorrhage
• Vitreous haemorrhage (sudden loss of vision)
• Retinal detachment
• Iris and angle NV cause secondary rubeotic glaucoma (very high 
intraocular pressure)
Iris new vessels
PDR
Tractional retinal detachment. The retina is being lifted away from the back of the eye 
by the traction in the vitreous.
Treatment for new vessels
• NV are caused by retinal ischaemia
• Retinal oxygen demand exceeds oxygen supply
• Scatter laser treatment (Pan Retinal Photocoagulation-PRP) reduces 
oxygen demand by destroying retinal tissue in a controlled way
• Typically 1200 to 5000 applications 
• Side effects  include
• field loss (problems for drivers)
• macular oedema (loss of visual acuity)
Vitrectomy
• Vitrectomy can be an essential vision saving operation in patients 
with persistent vitreous haemorrhage.
• The patient is also suspected of having active proliferative 
retinopathy, which cannot be seen behind the blood. Vitrectomy 
clears the haemorrhage so that the PRP can be done.
• The patient is suspected of having vitreous scarring and traction that 
is threatening to cause a retinal detachment. Vitrectomy allows the 
retina to be released and lasered to repair and prevent further 
detachment.
Treatment for PDR
Typical appearance after successful treatment
Screening for DR
• If onset of diabetes is <30 years of age, examine 
retina within 5 years of diagnosis and review 
annually
• If onset of diabetes is >30 years of age, examine 
retina at diagnosis and then annually
•During pregnancy, the retina should be 
examined once during every trimester

Preventing blindness from diabetic retinopathy
• All diabetics should understand how important it is to look after their 
bodies and must be helped and reminded of the following:
• Keep the blood sugar controlled. Patients should be taught how to 
supervise their own diabetic medication to keep the blood glucose 
level normal throughout the day.
• Keep the blood pressure controlled: aim for less than 140/80 mmHg.
• Keep to a strict, healthy diet and avoid obesity.
• Take exercise regularly.
• Avoid smoking.
• REGULAR SCREENING FOR DIABETIC RETINOPATHY
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QUIZ #1 True or False?
•People with diabetes are more likely than 
people without diabetes to develop certain eye 
diseases.
•True. Diabetic eye disease includes diabetic 
retinopathy—a leading cause of blindness in 
adults—cataract, and glaucoma. The longer 
someone has diabetes, the more likely he or 
she will develop diabetic eye disease.
#2 True or False
•Diabetic eye disease usually has early 
warning signs.
•False. Often there are none in the early 
stages of the disease. Vision may not 
change until the disease becomes 
severe.
#3 True or False
•People with diabetes should have yearly 
eye examinations.
•True. Everyone with diabetes should get 
an eye examination through dilated pupils 
at least once a year. Because diabetic eye 
disease usually has no symptoms, regular 
eye exams are important for early 
detection and timely treatment.
#4 True or False
•Diabetic retinopathy is caused by changes in 
the blood vessels in the eye.
•True. In some people, blood vessels in the 
retina may swell and leak fluid. In other 
people, abnormal new blood vessels grow 
on the surface of the retina.
#5 True or False
•People with diabetes are at low risk for 
developing glaucoma.
•False. Glaucoma is almost twice as likely to 
occur in people with diabetes than in those 
without the disease. Glaucoma can usually 
be treated with medications or laser or 
other surgery.
#6 True or False
•Laser surgery can be used to halt the 
progression of diabetic retinopathy.
•True. In laser surgery, a special beam of light 
is used to shrink the abnormal blood vessels 
or seal leaking blood vessels. Laser surgery 
has been proved to reduce the five-year risk 
of vision loss from advanced diabetic 
retinopathy by more than 90 percent.
#7 True or False
•People with diabetes should have regular 
eye examinations through dilated pupils.
•True. An eye examination through dilated 
pupils is the best way to detect diabetic eye 
disease, in which drops are used to enlarge 
the pupils. This allows the eye care 
professional to see more of the inside of the 
eye to check for signs of the disease.
#8 True or False
•Cataracts are common among people with 
diabetes.
•True. People with diabetes are twice as 
likely to develop cataracts and to develop 
them at an earlier age than are those 
without diabetes. Cataracts can usually be 
treated with surgery.
#9 True or False
•People who have good control of their diabetes 
are not at high risk for diabetic eye disease.
•False. Even with good control of blood glucose, 
there is still a risk of developing diabetic eye 
disease. However, studies show that careful 
management of blood sugar levels slows the 
onset and progression of diabetic retinopathy.
#10-- True or False
•The risk of blindness from diabetic 
eye disease can be reduced.
•True. With early detection and 
timely treatment, the risk of 
blindness from diabetic eye disease 
can be reduced.
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